KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with Sector Types Bioscience .

Opportunities In Analytical and Bioscience Market in Japan

Opportunities In Analytical and Bioscience Market in Japan 9:00 am UK time on Thursday 25 February.   Progress in analytical measurement technologies has seen rapid development in genetic analysis, protein marker discovery, metabolomics discovery, and cell research. As a result bio-research has emerged as a new segment of the market including genomics, proteomics...
Read More About Opportunities In Analytical and Bioscience Market in Japan »

Funding for Research Intensive SMEs: Don’t miss the next Eurostars

If you are a small company in need of public funding for your innovative idea, participation in a Eurostars project can bring you a passport to growth, further innovation, an opening to new global markets and even greater business success. Eurostars is the only European funding programme to be specifically dedicated to support  R&D-performing SMEs  in their innovative...
Read More About Funding for Research Intensive SMEs: Don’t miss the next Eurostars »

I-TAC Challenge Competition

Would your business benefit from up to six months free access to our laboratories, specialist facilities and equipment to accelerate your technology development?  Are you an SME undertaking R&D in the following technology or market sectors?  • Life Sciences • Chemical • Pharmaceutical  • Energy & Environment • Advanced Materials • Food Industry  ...
Read More About I-TAC Challenge Competition »

House of Commons Science and Technology Committee launches inquiry into impact of EU regulation & policy on UK life sciences

The Science and Technology Committee have launched an inquiry into the impact of EU regulation and policy on the UK life sciences. The inquiry will look at how EU legislation and regulation can best facilitate, and avoid impeding, collaboration and innovation in the life sciences with particular reference to the UK life sciences sector. Nicola Blackwood MP, Chair of the Science &...
Read More About House of Commons Science and Technology Committee launches inquiry into impact of EU regulation & policy on UK life sciences »

Biological systems: apply for business funding

The Ministry of Defence is to invest in SBRI competitions seeking new materials from biological systems. Up to £750,000 is available for proof-of-concept research into innovative uses of synthetic biology for materials such as for body armour A further £750,000 is available in fully funded business contracts for proof-of-concept research into the...
Read More About Biological systems: apply for business funding »

Roslin Cells announces the creation of two commercially focused subsidiaries

Roslin Cells Ltd., the Edinburgh and Cambridge based spin out from the world renowned Roslin Institute, announce that it has established two subsidiary companies to accelerate the expansion of its commercial operations.  Roslin Cell Therapies will carry forward its process development and manufacture of cell therapies for clinical trials.  Roslin Cell Sciences will focus on the...
Read More About Roslin Cells announces the creation of two commercially focused subsidiaries »

ReNeuron wins major UK grant to advance its exosome nanomedicine platform

ReNeuron Group plc, a leading UK-based stem cell therapy development company, announce that it has been awarded a £2.1 million grant from Innovate UK to further advance its emerging exosome nanomedicine platform. Read more here  
Read More About ReNeuron wins major UK grant to advance its exosome nanomedicine platform »

Quotient Clinical expands its formulation development services with the acquisition of Co-Formulate in Nottingham

Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has acquired formulation development specialist Co-Formulate Limited.  Quotient Clinical has brought innovation to the drug development process through its unique Translational Pharmaceutics platform, which challenges the conventional industry approach by integrating formulation development,...
Read More About Quotient Clinical expands its formulation development services with the acquisition of Co-Formulate in Nottingham »

Synpromics and Cell Therapy Catapult collaborate to develop viral vector manufacturing platform

Synpromics Ltd, a leading synthetic biology company, and The Cell Therapy Catapult, the UK organisation accelerating the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, announce the launch of a collaboration to remove a major barrier to the development of the cell and gene therapy industry by reducing the cost and...
Read More About Synpromics and Cell Therapy Catapult collaborate to develop viral vector manufacturing platform »

Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases

Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020    • No. 1 platform in rare diseases expected to generate 65% of total annual revenues  • Multiple, durable billion-dollar franchises, each with best-in-class products  • Robust portfolio includes...
Read More About Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases »

Midatech signs licencing agreement with Emergex Vaccines

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, have announced that the Company has entered into a licensing agreement with Emergex Vaccines Limited (“Emergex”), a private UK biotechnology company focused on infectious diseases utilising Midatech’s gold nanoparticle technology....
Read More About Midatech signs licencing agreement with Emergex Vaccines »

Oxford BioMedica Announces Successful MHRA Inspection and Approval to Manufacture at its new Facility

Oxford BioMedica plc, a leading gene and cell therapy group, have announced that it has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for Investigational Medicinal Products (IMPs) at the Group’s recently established and commissioned specialist biomanufacturing facility in Yarnton, Oxford, UK. The MHRA...
Read More About Oxford BioMedica Announces Successful MHRA Inspection and Approval to Manufacture at its new Facility »

Waters and BioCity to Establish an Open Access Analytical Laboratory in the BioHub at Alderley Park, UK

Laboratory will allow Waters a unique opportunity to further collaborate with scientists, while providing access to critical scientific infrastructure Waters Corporation  and  BioCity , the  UK's  largest bioscience incubator company, announced an agreement to launch an open access analytical laboratory. Located in the  BioHub  at  Alderley Park ,...
Read More About Waters and BioCity to Establish an Open Access Analytical Laboratory in the BioHub at Alderley Park, UK »

Advances in Cell & Tissue Culture: Call for Papers

Advances in Cell & Tissue Culture And the 8th Annual Quasi Vivo® User Group Meeting 30th May– 1 st June 2016 Hotel SB Plaza Europa, Barcelona, Spain ACTC  2016 is a forum for leading researchers to present their work  on in vitro cell culture and exchange ideas. It is a ‘Gordon  Style’ event encouraging everybody to contribute by  presenting a...
Read More About Advances in Cell & Tissue Culture: Call for Papers »

Medical Technologies IKC and Regener8 Annual Conference

The Regener8/IKC 2016 conference date has been set for 01 July 2016 (venue TBC) and we've already secured Professor Boris Chichkov from Laser Zentrum Hannover as keynote speaker. Don't miss out - follow the  registration link  to secure your place at this free - and highly worthwhile - event!
Read More About Medical Technologies IKC and Regener8 Annual Conference »

The new EPSRC CDT in Emergent Macromolecular Therapies will run its second cohort of PhD students in Oct 2016

The mission of the UCL The Centre for Doctoral Training in Emergent Macromolecular Therapies is to train the bioprocess engineering research leaders of the future who will deliver translation of new scientific advances into safely produced, more selective, therapies for currently intractable conditions at affordable costs. The CDT is funded by the Engineering and Physical Sciences...
Read More About The new EPSRC CDT in Emergent Macromolecular Therapies will run its second cohort of PhD students in Oct 2016 »

Pfizer plans to close a research unit in Cambridge

Pfizer plans to close a research unit in Cambridge, UK, with the loss of 120 jobs. The former Neusentis facility, located at Granta Park, is a discovery and development operation focused on treatments for pain. Pfizer told Manufacturing Chemist in a statement that following a review of its R&D strategy 'to ensure that it can develop breakthrough therapies that meet...
Read More About Pfizer plans to close a research unit in Cambridge »

Call for Participants for Partnership Brokering Visit to China

China-UK Newton Fund Research & Innovation Bridges Competition Call for Participants for Partnership Brokering Visit to China Deadline for applications:  GMT 5:00pm Tuesday 15 December 2015 Innovate UK, the Research Councils UK (RCUK) and the Ministry of Science and Technology (MoST) of the People’s Republic of China are investing up to...
Read More About Call for Participants for Partnership Brokering Visit to China »

Technology Inspired Innovation - Feasibility Studies Competition 2016 Briefing Events

Technology Inspired Innovation - Feasibility Studies Competition 2016 Briefing Events Briefing Events: Manchester 18th December 2015 Edinburgh 12th January 2016 London 26th January 2016 or join the Webinar These briefing events are an opportunity to find out about the specific funding rules and scope of this competition, find out how the KTN can support your...
Read More About Technology Inspired Innovation - Feasibility Studies Competition 2016 Briefing Events »

Innovation Opportunities from Waste

KTN with Innovate UK will host a workshop “Innovation Opportunities from Waste” on 14th January 2016 at the Studio in Manchester. The aim of this scoping workshop is to identify innovation challenges or opportunities related to the recovery of valuable materials from wastes arising from industrial activity in the UK. The workshop will explore potential opportunities for valorising waste...
Read More About Innovation Opportunities from Waste »

Competition for funding: Innovate UK to invest £2m in feasibility studies.

Innovate UK is to invest up to £2m in feasibility studies to  stimulate innovation across four enabling technology areas:  advanced materials; biosciences; electronics, sensors and  photonics; and information and communications. Innovate UK are seeking proposals that will kick-start the delivery of genuinely new products and services, with...
Read More About Competition for funding: Innovate UK to invest £2m in feasibility studies. »
Showing 76 - 96 of 96 results.
Items per Page 25
of 4